We recently reported that Alzheimer's disease (AD) with amygdala Lewy bodies (ALB) is a distinct form of -synucleinopathy that occurs in advanced AD. In AD/ ALB the -synuclein pathology correlated with tau pathology, but not amyloid plaques, and there was often co-localization of tau and -synuclein in the same neuron. Given the anatomical connectivity of the anterior olfactory nucleus and the amygdala, which receives axonal projections from the olfactory bulb, we hypothesized that there might be a relationship between tau and -synuclein pathology in the olfactory bulb and the amygdala in AD. We screened for -synuclein pathology in the olfactory bulb in AD with and without ALB, and investigated its relationship with tau pathology. In 38 of 41 (93%) AD/ALB cases and 4 of 21 (19%) AD cases without ALB (AD/non-ALB), -synuclein pathology was detected in the olfactory bulb. Double immunolabeling at the light and electron microscopic levels revealed co-localization of tau and -synuclein in the olfactory bulb neurons and neurites. The severity of tau pathology correlated with -synuclein pathology in the olfactory bulb. In addition, -synuclein pathology in the olfactory bulb correlated with -synuclein pathology in amygdala. Tau pathology was greater in both the olfactory bulb and amygdala in AD/ALB than in AD/non-ALB, but there was no diVerence in tau pathology between the two groups in other brain regions assessed. The present study shows that in AD/ALB, the olfactory bulb is nearly equally vulnerable to tau and -synuclein pathology as the amygdala and suggests that neurodegeneration in these two anatomical regions is linked.
Introduction
Tau is a microtubule-associated protein that becomes abnormally phosphorylated in aVected neurons of Alzheimer's disease (AD) [11, 19] to form Wlamentous aggregates in neuroWbrillary tangles (NFTs). Alpha-synuclein is a presynaptic protein that also forms Wlamentous inclusions as Lewy bodies (LBs) in aVected neurons of Parkinson's disease (PD) and dementia with Lewy bodies (DLB) [26] . LBs can be found in the brain of AD, and the amygdala is the most commonly aVected region [2, 13, 20] . We recently reported that AD with amygdala LBs (AD/ALB) is a distinct form of -synucleinopathy that occurs in the setting of advanced AD [30] . In AD/ALB, LBs are relatively conWned to amygdala, and the density of amygdala LBs correlates with the density of amygdala NFTs, but not with senile plaques. Immunoelectron microscopy has demonstrated co-localization of tau and -synuclein in the amygdala of AD/ALB, suggesting a close relationship between the two proteins in degenerating amygdala neurons [30] .
In another neuropathologic cohort, we also reported that -synuclein pathology is present in anterior olfactory nucleus of the olfactory bulb in all cases of Lewy body disease with concurrent NFTs [29] . Moreover, the severity of tau pathology in the olfactory bulb correlated with the density of amygdala LBs. Given the anatomical connectivity between the olfactory bulb and the amygdala, with anterior olfactory nucleus neurons projecting to the amygdala [24, 27] , we hypothesized that there might be correlations between tau and -synuclein pathology in the olfactory bulb and the amygdala in AD.
To address this issue, we screened for -synuclein pathology in the olfactory bulb of a series of cases of AD/ ALB as well as AD cases without ALB and correlated these Wndings with quantitative measures of tau pathology. Other neuronal populations that are vulnerable to -synuclein pathology were also screened for pathology. In a subset of cases, the changes in the olfactory bulb were further characterized by tau and -synuclein double immunolabeling at the light and electron microscopic levels.
Materials and methods

Case selections
Cases with complete neuropathologic evaluations that also had histologic sampling of the olfactory bulb were obtained from Mayo Clinic Jacksonville brain bank. AD/ALB was deWned as the presence of -synuclein immunoreactive neuronal cytoplasmic inclusions in the amygdala with minimal or no -synuclein pathology in other vulnerable brain regions. In some neurons, the lesions resembled cortical Lewy bodies, but in other neurons the inclusions were not well deWned on routine histologic stains. Nevertheless, such lesions were operationally referred to as "Lewy bodies" and Wt the classiWcation of AD/ALB. All cases met the pathological criteria for high likelihood AD, according to NIA-RI criteria [14] and had Braak NFT stage [5] of V or greater. Cases were excluded if they had any other vascular pathology, hippocampal sclerosis or tauopathy (e.g., argyrophilic grain disease) [1, 9, 28] . A total of 41 cases of AD/ ALB were matched with a consecutive series of 21 AD cases without ALB (AD/non-ALB) that were matched for age, sex, brain weight and Braak NFT stage (Table 1) .
Immunohistochemistry
Single immunostaining was the same as previously described with a monoclonal antibody to phospho-tau (CP13; 1:1,000) [31] and a rabbit polyclonal antibody to -synuclein (NACP; 1:3,000) [12] . The deparaYnized and rehydrated sections were pretreated with 95% formic acid for 30 min and then steamed in distilled water for 30 min for NACP; the formic acid pretreatment was omitted for CP13. Immunohistochemistry was performed with a DAKO Autostainer (DAKO, Carpinteria, CA, USA) using 3, 3Ј-diaminobenzidine (DAB) as the chromogen. After immunostaining, the sections were lightly counterstained with hematoxylin.
Co-localization of -synuclein and tau epitopes was studied using paraYn sections of the amygdala and olfactory bulb in six cases of AD/ALB. DeparaYnized sections were treated with hydrogen peroxide to block endogenous peroxidase activity, followed by normal serum to block nonspeciWc antibody binding. The sections were then incubated with a cocktail of primary antibodies: NACP (1:2,000) and mouse monoclonal IgG 1 antibody to tau (PHF-1; 1:100; Dr. Peter Davies, Einstein College of Medicine, New York, USA) [16] . They were then rinsed and incubated with a mixture of horseradish peroxidase conjugated anti-mouse IgG 1 and alkaline phosphatase conjugated anti-rabbit IgG. Antibodies were visualized with DAB and then Sigma Fast TM 5-bromo-4-chloro-3-indolyl phosphate/ nitro blue tetrazolium (pH 9.5) as chromogens.
Evaluation of tau pathology
ThioXavin-S Xuorescent microscopy was used for counting NFTs (at £400) in the cortical transitional region of the amygdala and in the association cortices, including midfrontal, superior temporal and inferior parietal lobes [29, 30] . The olfactory bulb mainly projects to the cortical nuclei of amygdala, consistent with the region studied [24, 27] . The presence and severity of tau pathology (NFT and neuropil threads) were scored in the olfactory bulb on CP13-immunostained sections with a semi-quantitative method (0: none, 1: sparse to mild, 2: moderate, 3: severe). The scoring was performed blinded to pathologic diagnoses.
Evaluation of -synuclein pathology
The presence and severity of -synuclein pathology (LBs and Lewy related neurites) was scored in the olfactory bulb, amygdala, substantia nigra (SN), locus ceruleus (LC), dorsal motor nucleus of vagus (DMN), nucleus basalis of 
Meynert (nbM), entorhinal cortex (ERC) and anterior cingulate gyrus (CG) with a semi-quantitative method (0: none, 1: sparse to mild, 2: moderate, 3: severe). In addition to perikaryal LBs, this assessment also considered intraaxonal LBs, cortical-type LBs, pleomorphic LBs and Lewy neurites. Scoring was performed blinded to pathologic diagnoses. Cases were assigned a Braak PD stage [6] based upon the distribution of Lewy bodies; however, many cases failed to Wt the staging scheme and are so indicated in Table 2 .
Immunoelectron microscopy (IEM)
Formalin-Wxed olfactory bulbs were processed for embedding in LR White resin as previously described [30] . For double labeling, sections were incubated overnight at 4°C with NACP diluted 1:20 or with undiluted tau monoclonal antibody supernatants. After washing, they were labeled with a mixture of colloidal gold-conjugated goat antibodies against rabbit or mouse IgG (1: 20 in PBS) for 30 min at room temperature. The goat anti-rabbit and anti-mouse IgG were conjugated with 5 and 18 nm gold particles (Amersham Biosciences; Piscataway, NJ, USA and Jackson Immuno Research Laboratories; West Grove, PA, USA), respectively. After washing, the sections were brieXy stained with uranyl and lead before examination with a Philips 208S electron microscope.
Statistical methods
Data were analyzed by using Sigma Stat for Windows, 3.0 (Systat Software, Inc. Point Richmond, CA, USA), and a signiWcance level was set at P < 0.05. Demographics and pathological measures for the two groups were analyzed with a Mann-Whitney U test or a student's t-test, as appropriate. Spearman's rank order correlation was used to evaluate correlations between -synuclein scores in the olfactory bulb with other pathological measures.
Results
Alpha-synuclein pathology in the olfactory bulb Alpha-synuclein immunoreactive pathology in the olfactory bulb was found in 4 of 21 AD/non-ALB (19%) and 38 of 41 AD/ALB (93%), respectively. The isolated -synuclein pathology in the olfactory bulb in AD/non-ALB was predominantly sparse Lewy neurites rather than Lewy bodies, suggestive of an early stage of Lewy body pathology. The presence and distribution of severity of -synuclein for all cases is shown in Table 2 . In AD/non-ALB group, three cases had -synuclein pathology conWned to the olfactory bulb, and one case had -synuclein pathology in both the olfactory bulb and the locus ceruleus, but not in other brain regions vulnerable to LBs. In contrast, in all but three cases of AD/ALB, there was -synuclein pathology in the olfactory bulb as well as the amygdala. In these three cases, -synuclein pathology was sparse in the amygdala, but none was detected in the olfactory bulb. The frequency of -synuclein pathology in the olfactory bulb and amygdala was nearly the same (68 and 66%, respectively). Only 11% of all cases had -synuclein pathology in DMN, where Lewy body pathology is proposed to begin in Parkinson's disease (PD) according to the Braak PD staging scheme [7, 8] .
More than half of AD/ALB cases had sparse -synuclein pathology in either brainstem or limbic areas ( Table 2 ). This pathology was not apparent with hematoxylin and eosin-stained sections as previously reported and was most often characterized by neurites and pale bodies [30] .
Co-localization of tau and -synuclein in the olfactory bulb Double labeling IHC showed co-localization of tau and -synuclein in many neurons in the amygdala (Fig. 1a ) and in the olfactory bulb (Fig. 1b) . The two proteins were either separate structures within the same neuron or partially overlapping. Only rarely did tau and -synuclein immunoreactivities perfectly overlap. Ultrastructural analyses of olfactory bulb neurons showed that the tau-positive Wlaments were either paired helical Wlaments (PHF) or straight Wlaments (SF), while -synuclein-positive structures were composed of granular dense material associated with Wlaments thinner than tau Wlaments (Figs. 2, 3 ). This was true in both cell bodies (Fig. 2) and neurites (Fig. 3) in the olfactory bulb. Most of the tau Wlaments formed tightly packed bundles, while -synuclein-labeled Wlaments were dispersed and not bundled. Scattered tau Wlaments were occasionally found within -synuclein aggregates, but -synuclein Wlaments were largely excluded from the tau Wlament bundles. Double labeling results gave the same results when the size of the colloidal gold conjugates was reversed. The Wndings in the olfactory bulb were similar to those in amygdala neurons [30] .
Comparison of the severity of tau pathology in the olfactory bulb
The density of NFTs in the cortical transitional zone of the amygdala were signiWcantly greater in AD/ALB compared to AD/non-ALB (P < 0.05; Fig. 4) , which is similar to our previous report [30] . In contrast, the average NFT density in association cortices and the Braak NFT stage were not diVerent between two groups (Fig. 4) . All cases had CP13 immunoreactive tau pathology in the olfactory bulb. Semiquantitative scores for tau pathology and -synuclein pathology in the olfactory bulb were both greater in AD/ ALB than in AD/non-ALB (P < 0.001; Fig. 5 ).
Correlation between -synuclein pathology in olfactory bulb and other pathological measures
The relationship between the semi-quantitative score for -synuclein pathology in olfactory bulb was correlated with other pathologic variables in various brain regions with Spearman's rank order correlation. The -synuclein score in the olfactory bulb correlated with the tau score in the olfactory bulb (r = 0.44, P < 0.01), but not with the density of NFT in the amygdala or association cortices. The -synuclein score in the olfactory bulb also correlated with the -synuclein score in amygdala (r = 0.33, P < 0.05), but not with -synuclein score in the brainstem nuclei or limbic cortices.
Discussion
In this study, most AD/ALB cases had olfactory bulb -synuclein pathology in the olfactory bulb, while the majority of AD/non-ALB cases did not, suggesting a close relationship of -synuclein pathology between olfactory bulb and amygdala in AD/ALB. This is the Wrst study that examines -synuclein pathology in both olfactory bulb and amygdala in a relatively large number of AD cases. The results suggest that the olfactory bulb, in addition to the amygdala, is vulnerable to -synuclein pathology in AD. Braak et al. hypothesized that Lewy body pathology begins in the DMN and olfactory bulb in Parkinson's disease (PD) [7] . Bloch et al. examined incidental Lewy body disease, which is regarded as a presymptomatic phase of PD, and found that 100% of cases had -synuclein pathology in the olfactory bulb and DMN, while 69% also had involvement of the amygdala, consistent with the PD Braak scheme [4] . In the current study, the distribution of -synuclein pathology in AD/ALB brains does not Wt with the Braak PD staging scheme [7] , and is consistent with other studies of -synuclein pathology in AD [5, 17, [21] [22] [23] 30] . We found isolated -synuclein pathology in either the olfactory bulb or amygdala in a few cases, but in most cases, both regions were aVected. When only one region was aVected, the pathology was mostly neuritic and sparse, suggesting that it was an early pathological process. The results suggest that when -synuclein pathology occurs in the setting of advanced AD, the olfactory bulb and amygdala are aVected simultaneously, which is not directly linked to pathology in the vulnerable nuclei at the lower levels of the neuraxis. When the process widens, the limbic lobe appears to have equal or greater vulnerability to brainstem nuclei aVected with PD.
The relationship between tau and -synuclein in the same neuron is similar in the amygdala and olfactory bulb at the light and electron microscopic levels. In the present study, tau and -synuclein Wlaments were detected not only in neuronal perikarya, but also in neurites. The major Wnding is that the lesions are characterized by two populations of Wlaments, with no evidence supporting that copolymers formed tau and -synuclein molecules, despite the in vitro evidence that tau and -synuclein are able to reciprocally seed Wlament formation [10] . While tau Wlaments can occasionally be intermingled with -synuclein Wlaments, the reverse is not true, especially for tightly packed bundles of tau Wlaments; in most cases, they are separate or juxtaposed aggregates. This pattern of colocalization of tau and -synuclein is similar to those reported in hippocampal and brainstem neurons in LBD [3, 16] .
The tau Wlaments were composed of both SFs and PHFs. In contrast, most NFTs in AD are composed of PHFs. Whether the increased frequency of SFs is due to -synuclein remains unknown. In vitro studies showed that -synuclein could bind to tau and stimulate tau phosphorylation by protein kinase A [18] . On the other hand, Souza et al. showed that -synuclein inhibited aggregation of insulin, suggesting a negative chaperone-like activity [25] . Similarly, the ill-deWned LBs could be due to the presence of abnormal tau, hindering the formation of well-deWned LBs. In another immunoelectron microscopic study, Iseki et al. identiWed non-Wlamentous components in LBs, which may be an early stage of LB formation [15] .
We showed that brains of AD/ALB cases had more severe tau pathology in amygdala and olfactory bulb than the brains of AD/non-ALB cases. In contrast, cortical NFT burden was similar as assessed by average NFT counts in association cortices and the Braak NFT stage. This diVerence is not related to any obvious demographic variable, as cases were matched ( Table 1 ). The Wndings suggest that a subset of AD may have disproportionately severe limbic system neuroWbrillary degeneration that makes them uniquely vulnerable to -synuclein pathology. Fig. 4 Comparison of NFT counts in amygdala and association cortices between AD with and without amygdala Lewy bodies (ALB). The NFT count in amygdala was signiWcantly higher in AD with ALB (AD/ ALB) than those in AD without ALB (AD/non-ALB) (*P < 0.05), while there was no diVerence in NFT count in association cortices AD/ ALB and AD/non-ALB. MF mid frontal cortex, ST superior temporal cortex, IP inferior parietal cortex Fig. 5 Comparison of mean -synuclein and tau score in olfactory bulb between AD with and without amygdala Lewy bodies (ALB). Alpha-synuclein and tau scores in olfactory bulb are greater in AD/ ALB than those of AD/non-ALB (*P < 0.001)
